Related Experiment Video
Updated: Feb 18, 2026

10:38
A Modified Surgical Technique for Kidney Transplantation in Mice
Published on: July 22, 2022
7.3K
Death with graft function after kidney transplantation: a single-center experience
Mi-Yeon Yu1, Yong Chul Kim1, Jung Pyo Lee2
1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Clinical and Experimental Nephrology
|November 22, 2017
Summary
Death with graft function (DWGF) is a major reason for kidney transplant loss. Infection and malignancy are the primary causes, necessitating vigilant monitoring post-transplantation to improve graft survival.
Area of Science:
- Nephrology
- Transplantation Immunology
- Clinical Medicine
Background:
- Death with graft function (DWGF) significantly contributes to long-term kidney allograft and patient loss.
- Understanding the clinical profile and etiology of DWGF is crucial for improving transplant outcomes.
Purpose of the Study:
- To investigate the clinical characteristics of kidney transplant recipients experiencing death with graft function (DWGF).
- To identify the primary causes of DWGF in kidney allograft recipients.
Main Methods:
- A retrospective analysis of 2137 kidney allograft recipients transplanted between 1973-2016 at Seoul National University Hospital.
- Recipients were categorized into four groups: alive with graft function (AWGF), alive with graft loss (AWGL), DWGF, and death with graft loss (DWGL).
Main Results:
- DWGF accounted for 19.3% of graft loss due to death and 38.6% of all deaths among recipients with graft loss.
- DWGF patients were older, more frequently diabetic, and had higher rates of delayed graft function compared to other groups.
- Infection (40.9%), malignancy (28.4%), and cardiovascular disease (11.4%) were the leading causes of DWGF, with infection-related deaths peaking within the first year post-transplant.
Conclusions:
- DWGF represents a substantial cause of kidney allograft loss in the studied cohort.
- Infection and malignancy are the predominant drivers of DWGF throughout the post-transplantation period.
- Enhanced surveillance for infection and malignancy is recommended to mitigate graft loss.
Related Concept Videos
Kidney Transplant I: Introduction
534
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
534
Kidney Transplant II: Surgical Procedure
487
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
487
Kidney Transplant III: Nursing Management
419
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
419
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Acute Kidney Injury III: Clinical Manifestations
1.0K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K

